REL and lymphoid neoplasm: After treatment, we observed a striking reduction in lymphoid tumour burden in all mice re-implanted with Eμ-Myc/cRel−/− lymphoma cells and treated with GDC-0941 (Figure 3D, Supplementary Figure S7A,B).